4D Molecular Therapeutics FDMT Market capitalization

Market capitalization at other companies

Eli LillyLLY

$1.07T+53.1%

Regeneron PharmaceuticalsREGN

$65.37B+15.9%

Vertex PharmaceuticalsVRTX

$126.07B+9.0%

EyePoint, Inc.EYPT

$1.2B+89.8%

AbbVieABBV

$444.6B+35.6%

RegenxbioRGNX

$619.34M+43.6%

FAQ

What is 4D Molecular Therapeutics's market capitalization?

4D Molecular Therapeutics (FDMT) reported market capitalization of $475.29M in Q1 2026.

How has 4D Molecular Therapeutics's market capitalization changed year-over-year?

4D Molecular Therapeutics's market capitalization increased by 217.8% year-over-year, from $149.56M to $475.29M.

What is the long-term trend for 4D Molecular Therapeutics's market capitalization?

Over 5 years (2020 to 2025), 4D Molecular Therapeutics's market capitalization has grown at a -17.3% compound annual growth rate (CAGR), from $1.11B to $428.51M.

What does market capitalization mean?

The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.